Enlivex Therapeutics Ltd.

FSX : 1BT

Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.

Information

Website
https://www.enlivex.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
Israel

Price

EUR 1.41

Symbol

1BT

Type

Common Stock

Previous Close

 :

1.16

52 Week Range

 :

1.04 - 3.92

Volume

 :

0.00

Average Volume

 :

1,800.00

High

 :

1.41

Low

 :

1.41

Change

 :

0.25

Percent change (%)

 :

21.55

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...